Brief: UCB Receives U.S. FDA Approval For Bimzelx

UCB SA

20/11/2024 06:06

Nov 20 (Reuters) - Ucb SA  UCB.BR :
    * RECEIVES U.S. FDA APPROVAL FOR BIMZELX(BIMEKIZUMAB-BKZX)
AS
FIRST IL-17A AND IL-17F INHIBITOR FOR ADULTS WITH MODERATE TO
SEVERE HIDRADENITIS SUPPURATIVA
    * APPROVAL IS SUPPORTED BY DATA FROM TWO PHASE 3 STUDIES, BE
HEARD
I AND BE HEARD II

Source text:  ID:nNDL295pXp 
Further company coverage:  UCB.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))